• Title of article

    [188Re]Rhenium Sulfide Suspension: A Potential Radiopharmaceutical for Tumor Treatment Following Intra-Tumor Injection

  • Author/Authors

    Junfeng، Yu نويسنده , , Duanzhi، Yin نويسنده , , Xiaofeng، Min نويسنده , , Zili، Guo نويسنده , , ZhangJiong، نويسنده , , Yongxian، Wang نويسنده , , Jr، F.F. Knapp نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 1999
  • Pages
    -572
  • From page
    573
  • To page
    0
  • Abstract
    Amajor liabilitv facing the owners and operators of nuclear facilities worldwide is the decontamination and decommissioning ( D& D ) of contaminated massive concrete structures. A biodecontamination technology which harnesses the action of naturally occurring bacteria is currently under joint development by BNFL and the Idaho National Engineering and Environmental Laboratory. This emerging technology was judged to exhibit advantages in cost, worker health and safety risk reduction, and programmatic effectiveness. The process takes approximately six months to one year to remove the contaminated surface and can advantageously be applied during the care and maintenance phase of a D&D programme. A detailed assessment of the biodecontamination process in relation to the next best and base technologies was performed. The findings of this study, which recommended a large-scale technology demonstration, will be presented.
  • Keywords
    Tumor-inhibiting ratio , Intra-tumor injection , biodistribution , suspension
  • Journal title
    NUCLEAR MEDICING & BIOLOGY
  • Serial Year
    1999
  • Journal title
    NUCLEAR MEDICING & BIOLOGY
  • Record number

    29474